{"id":10798,"date":"2021-09-10T14:21:40","date_gmt":"2021-09-10T11:21:40","guid":{"rendered":"https:\/\/fairlifelcc.com\/?p=10798"},"modified":"2025-01-05T00:57:51","modified_gmt":"2025-01-05T00:57:51","slug":"revolutionary-lung-cancer-drug-made-available-on-nhs-in-england","status":"publish","type":"post","link":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/","title":{"rendered":"Revolutionary\u2019 lung cancer drug made available on NHS in England"},"content":{"rendered":"

 <\/p>\n

\n
\n

Patients in England first to benefit from Sotorasib after drug proven to halt growth of tumours for seven months<\/strong><\/p>\n<\/div>\n<\/div>\n

\n
\n
<\/div>\n<\/div>\n<\/div>\n

 <\/p>\n

Lung cancer patients in England will become the first in Europe to benefit from a \u201crevolutionary\u201d new drug that can halt the growth of tumours by targeting the so-called \u201cDeath Star\u201d mutation.<\/p>\n

The medication, Sotorasib, will be fast-tracked to\u00a0NHS<\/a>\u00a0patients after it was proven in clinical trials to stop lung cancer growing for seven months.<\/p>\n

The drug targets the mutation on the KRAS gene, which is found in a quarter of all tumours and is known as the \u201cDeath Star\u201d mutation because of its spherical appearance and impenetrable nature.<\/p>\n

\u201cSotorasib is one of the most exciting breakthroughs in lung cancer treatment in 20 years, targeting a cancer gene that was previously untargetable and built on decades of laboratory research that\u2019s unravelled cancer\u2019s inner workings,\u201d said Prof Charles Swanton,\u00a0Cancer<\/a>\u00a0Research UK\u2019s chief clinician. \u201cThis medicine expands our list of effective precision therapies in lung cancer that are helping to improve survival for patients with limited options. It\u2019s great news that patients in England will now benefit from this novel treatment.\u201d<\/p>\n

Initially, about 600 lung cancer patients will be given the drug in England within weeks after an early access deal was struck with the manufacturer Amgen UK. Sotorasib, taken as a tablet, binds with the KRAS G12C mutation and makes it inactive, stopping cell division and cancer growth. Eventually, thousands of cancer patients are likely to benefit from the drug.<\/p>\n

Following approval by the Medicines and Healthcare products Regulatory Agency (MHRA), the\u00a0National Institute for Health and Care Excellence<\/a>\u00a0(Nice) and Amgen have reached a national agreement to enable early access to the drug for eligible lung cancer patients in England while Nice completes its ongoing appraisal.<\/p>\n

Amanda Pritchard, the NHS chief executive, said: \u201cThe NHS has a strong track record of securing best-value access to world-class treatments for our patients, and this lung cancer drug, decades in the making, is the latest deal landed by the health service in England which will save lives.\u201d<\/p>\n

NHS England recently secured several other drug deals, including a cholesterol-lowering jab expected to prevent about 55,000 heart attacks in the next three years, and Osimertinib, another lung cancer drug that aims to reduce the chance of cancer returning.<\/p>\n

It comes as the health service continues its latest phase of its Help Us to Help You campaign, urging nyone experiencing symptoms or unusual changes \u2013 such as a persistent cough that is not Covid, coughing up blood, a lump in the tummy or breast area, post-menopausal bleeding, or unexplained weight loss \u2013 to contact their GP immediately, as these can also be signs of cancer.<\/p>\n

 <\/p>\n

Source : www.theguardian.com\u00a0<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

  Patients in England first to benefit from Sotorasib after drug proven to halt growth of tumours for seven months   Lung cancer patients in…<\/p>\n","protected":false},"author":6,"featured_media":10799,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-10798","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","description-off"],"acf":[],"yoast_head":"\nRevolutionary\u2019 lung cancer drug made available on NHS in England - FairLife L.C.C.<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revolutionary\u2019 lung cancer drug made available on NHS in England - FairLife L.C.C.\" \/>\n<meta property=\"og:description\" content=\"  Patients in England first to benefit from Sotorasib after drug proven to halt growth of tumours for seven months   Lung cancer patients in...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/\" \/>\n<meta property=\"og:site_name\" content=\"FairLife L.C.C.\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-10T11:21:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-05T00:57:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fairlife.catalyticademo.com\/wp-content\/uploads\/2021\/09\/5000-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"372\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Korina Bell\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Korina Bell\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/\",\"url\":\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/\",\"name\":\"Revolutionary\u2019 lung cancer drug made available on NHS in England - FairLife L.C.C.\",\"isPartOf\":{\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fairlife.catalyticademo.com\/wp-content\/uploads\/2021\/09\/5000-1.jpg\",\"datePublished\":\"2021-09-10T11:21:40+00:00\",\"dateModified\":\"2025-01-05T00:57:51+00:00\",\"author\":{\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/#\/schema\/person\/8667010410e2ad75dd75168aa3bef50a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#primaryimage\",\"url\":\"https:\/\/fairlife.catalyticademo.com\/wp-content\/uploads\/2021\/09\/5000-1.jpg\",\"contentUrl\":\"https:\/\/fairlife.catalyticademo.com\/wp-content\/uploads\/2021\/09\/5000-1.jpg\",\"width\":620,\"height\":372},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0391\u03c1\u03c7\u03b9\u03ba\u03ae\",\"item\":\"https:\/\/fairlife.catalyticademo.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revolutionary\u2019 lung cancer drug made available on NHS in England\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/#website\",\"url\":\"https:\/\/fairlife.catalyticademo.com\/en\/\",\"name\":\"FairLife L.C.C.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fairlife.catalyticademo.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/#\/schema\/person\/8667010410e2ad75dd75168aa3bef50a\",\"name\":\"Korina Bell\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fairlife.catalyticademo.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1081e482d3a7d3e662bb628615d3b925567afb279dc6abf357280401de925771?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1081e482d3a7d3e662bb628615d3b925567afb279dc6abf357280401de925771?s=96&d=mm&r=g\",\"caption\":\"Korina Bell\"},\"url\":\"https:\/\/fairlife.catalyticademo.com\/en\/author\/korina-bell-2\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revolutionary\u2019 lung cancer drug made available on NHS in England - FairLife L.C.C.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Revolutionary\u2019 lung cancer drug made available on NHS in England - FairLife L.C.C.","og_description":"  Patients in England first to benefit from Sotorasib after drug proven to halt growth of tumours for seven months   Lung cancer patients in...","og_url":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/","og_site_name":"FairLife L.C.C.","article_published_time":"2021-09-10T11:21:40+00:00","article_modified_time":"2025-01-05T00:57:51+00:00","og_image":[{"width":620,"height":372,"url":"https:\/\/fairlife.catalyticademo.com\/wp-content\/uploads\/2021\/09\/5000-1.jpg","type":"image\/jpeg"}],"author":"Korina Bell","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Korina Bell","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/","url":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/","name":"Revolutionary\u2019 lung cancer drug made available on NHS in England - FairLife L.C.C.","isPartOf":{"@id":"https:\/\/fairlife.catalyticademo.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#primaryimage"},"image":{"@id":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#primaryimage"},"thumbnailUrl":"https:\/\/fairlife.catalyticademo.com\/wp-content\/uploads\/2021\/09\/5000-1.jpg","datePublished":"2021-09-10T11:21:40+00:00","dateModified":"2025-01-05T00:57:51+00:00","author":{"@id":"https:\/\/fairlife.catalyticademo.com\/en\/#\/schema\/person\/8667010410e2ad75dd75168aa3bef50a"},"breadcrumb":{"@id":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#primaryimage","url":"https:\/\/fairlife.catalyticademo.com\/wp-content\/uploads\/2021\/09\/5000-1.jpg","contentUrl":"https:\/\/fairlife.catalyticademo.com\/wp-content\/uploads\/2021\/09\/5000-1.jpg","width":620,"height":372},{"@type":"BreadcrumbList","@id":"https:\/\/fairlife.catalyticademo.com\/en\/revolutionary-lung-cancer-drug-made-available-on-nhs-in-england\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0391\u03c1\u03c7\u03b9\u03ba\u03ae","item":"https:\/\/fairlife.catalyticademo.com\/en\/"},{"@type":"ListItem","position":2,"name":"Revolutionary\u2019 lung cancer drug made available on NHS in England"}]},{"@type":"WebSite","@id":"https:\/\/fairlife.catalyticademo.com\/en\/#website","url":"https:\/\/fairlife.catalyticademo.com\/en\/","name":"FairLife L.C.C.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fairlife.catalyticademo.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fairlife.catalyticademo.com\/en\/#\/schema\/person\/8667010410e2ad75dd75168aa3bef50a","name":"Korina Bell","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fairlife.catalyticademo.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1081e482d3a7d3e662bb628615d3b925567afb279dc6abf357280401de925771?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1081e482d3a7d3e662bb628615d3b925567afb279dc6abf357280401de925771?s=96&d=mm&r=g","caption":"Korina Bell"},"url":"https:\/\/fairlife.catalyticademo.com\/en\/author\/korina-bell-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/posts\/10798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/comments?post=10798"}],"version-history":[{"count":1,"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/posts\/10798\/revisions"}],"predecessor-version":[{"id":52743,"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/posts\/10798\/revisions\/52743"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/media\/10799"}],"wp:attachment":[{"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/media?parent=10798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/categories?post=10798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fairlife.catalyticademo.com\/en\/wp-json\/wp\/v2\/tags?post=10798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}